v3 Template
S

Sensorion

Biotechnology / Healthcare Boston, USA; Miami, USA ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$135.5M
Funding Rounds
3
Last Funding
2026-01-28

About Sensorion

Sensorion is a pioneering clinical-stage biotech company focused on developing novel therapies to restore, treat, and prevent hearing loss disorders. Their mission is to offer innovative therapeutic solutions for long-term improvements to people with inner ear disorders, addressing significant unmet medical and social needs through three pillars: Restore, Treat, and Prevent.

Products & Services

OTOF-GT:A product focused on treating genetic hearing loss disorders.
SENS-401:A therapeutic solution aimed at treating hearing disorders.
GJB2-GT:A product targeting genetic causes of hearing loss.
Restore Program:Aims to restore hearing by treating genetic diseases previously considered untreatable.
Treat Program:Focuses on treating hearing disorders through innovative small molecule therapeutic solutions.
Prevent Program:Aims to prevent non-genetic hearing loss (e.g., drug or surgery-related) through targeted therapeutic programs.

Specialties

Hearing loss disorders Inner ear disorders Genetic hearing loss treatments Small molecule therapeutics Preventive therapies for hearing loss

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Reserved Offering (Equity Financing)
T: -
FT: Reserved Offering (Equity Financing) 		A: 66000000
MR: -
FA: €60 million
FAN: 66000000 		D: 2026-01-28
FD: 2026-01-28 		7 investors
2 RT: Reserved Offering
T: -
FT: Reserved Offering 		A: 15000000
MR: -
FA: €15 million
FAN: 15000000 		D: 2024-04-08
FD: 2024-04-08 		4 investors
3 RT: Private Placement
T: -
FT: Private Placement 		A: 54540000
MR: -
FA: €50.5 million
FAN: 54540000 		D: 2024-02-09
FD: 2024-02-09 		4 investors
Reserved Offering (Equity Financing) Latest
2026-01-28
$66.0M
7 investors (Pro only)
Reserved Offering 2024-04-08
$15.0M
Private Placement 2024-02-09
$54.5M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Nawal Ouzren

CEO and Director

LinkedIn (Pro only)
G

Géraldine Honnet

Chief Medical Officer

LinkedIn (Pro only)
B

Bernd Schmidt

Chief Technical Officer

LinkedIn (Pro only)
L

Laurene Danon

Chief Financial Officer

S

Stéphanie Filipe

Head of Business Operations & Portfolio Management

L

Laurent Désiré

Head of Preclinical Development

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Sensorion Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~480 employees (est.)
Locations
Boston, USA; Miami, USA
Orlando, Florida, USA
Marrakech, Morocco +3 more

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro